PAPER van Vliet EA, da Costa Araújo S, Redeker S, van Schaik R, Aronica E, Gorter JA
SEARCH RESULTS
330712 RESULTS
PAPER Monacelli F, Poggi A, Storace D, Durante A, Traverso N, Viviani GL, Odetti P
Effects of valsartan therapy on protein glycoxidation.
Metabolism. 2006 Dec;55(12):1619-24. PubMed: 17142134PAPER Badowska-Szalewska E, Klejbor I, Dziwiatkowski J, Spodnik JH, Moryś J
The influence of acute and chronic open-field exposure on the hippocampal formation: an immunohistochemical study.
Folia Morphol (Warsz). 2006 Nov;65(4):343-51. PubMed: 17171614PAPER Gilliam FG, Maton BM, Martin RC, Sawrie SM, Faught RE, Hugg JW, Viikinsalo M, Kuzniecky RI
Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy.
Neurology. 2007 Jan 30;68(5):364-8. PubMed: 17261683PAPER Greenamyre JT
Huntington's disease--making connections.
N Engl J Med. 2007 Feb 1;356(5):518-20. PubMed: 17267914PAPER Egger B, Chell JM, Brand AH
Insights into neural stem cell biology from flies.
Philos Trans R Soc Lond B Biol Sci. 2008 Jan 12;363(1489):39-56. PubMed: 17309865PAPER Schneider BL, Seehus CR, Capowski EE, Aebischer P, Zhang SC, Svendsen CN
Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation.
Hum Mol Genet. 2007 Mar 15;16(6):651-66. PubMed: 17309880PAPER Ryan DA, Federoff HJ
Translational considerations for CNS gene therapy.
Expert Opin Biol Ther. 2007 Mar;7(3):305-18. PubMed: 17309323PAPER Blard O, Feuillette S, Bou J, Chaumette B, Frébourg T, Campion D, Lecourtois M
Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila.
Hum Mol Genet. 2007 Mar 1;16(5):555-66. PubMed: 17309878PAPER Nicolay JP, Gatz S, Liebig G, Gulbins E, Lang F
Amyloid induced suicidal erythrocyte death.
Cell Physiol Biochem. 2007;19(1-4):175-84. PubMed: 17310111PAPER Simonsen AH, Hansson SF, Ruetschi U, McGuire J, Podust VN, Davies HA, Mehta P, Waldemar G, Zetterberg H, Andreasen N, Wallin A, Blennow K
Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods.
Dement Geriatr Cogn Disord. 2007;23(4):246-50. Epub 2007 Feb 19 PubMed: 17310122PAPER Matsumoto Y, Yanase D, Noguchi-Shinohara M, Ono K, Yoshita M, Yamada M
Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
Dement Geriatr Cogn Disord. 2007;23(4):241-5. PubMed: 17310121PAPER Kadir A, Darreh-Shori T, Almkvist O, Wall A, Långström B, Nordberg A
Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.
Psychopharmacology (Berl). 2007 May;191(4):1005-14. PubMed: 17310387PAPER Ames D, Ritchie C
Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
Int Psychogeriatr. 2007 Feb;19(1):1-8. PubMed: 17310512PAPER Bodine C, Scherer MJ
Technology for improving cognitive function. A workshop sponsored by the US Interagency Committee on Disability Research (ICDR): reports from working groups.
Disabil Rehabil. 2006 Dec 30;28(24):1567-71. PubMed: 17178621Current Filters
- Date Range : All x